Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
ATP + L-asparagine + tRNAAsn
AMP + diphosphate + L-asparaginyl-tRNAAsn
-
-
-
?
ATP + L-asparagine + tRNAAsn
AMP + diphosphate + L-asparaginyl-tRNAAsn
additional information
?
-
ATP + L-asparagine + tRNAAsn
AMP + diphosphate + L-asparaginyl-tRNAAsn
-
-
-
?
ATP + L-asparagine + tRNAAsn
AMP + diphosphate + L-asparaginyl-tRNAAsn
-
-
?
ATP + L-asparagine + tRNAAsn
AMP + diphosphate + L-asparaginyl-tRNAAsn
-
-
?
ATP + L-asparagine + tRNAAsn
AMP + diphosphate + L-asparaginyl-tRNAAsn
tRNAs from calf liver or Saccharomyces cerevisiae
-
?
ATP + L-asparagine + tRNAAsn
AMP + diphosphate + L-asparaginyl-tRNAAsn
-
with the aminoacylation step E + AA + ATP = E(AA-AMP) + diphosphate, and the amidation step E(AA-AMP) + tRNA = E+AA-tRNA + AMP
-
-
r
additional information
?
-
-
human cytoplasmic aminoacyl-tRNA synthetases, which are autoantigens in idiopathic inflammatory myopathies, activate chemokine receptors on T lymphocytes, monocytes, and immature dendritic cells by recruiting immune cells that could induce innate and adaptive immune responses
-
-
?
additional information
?
-
-
active site and ligand binding structure and mechanism, overview
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Alzheimer Disease
Alzheimer's Disease Risk Variant rs2373115 Regulates GAB2 and NARS2 Expression in Human Brain Tissues.
Ataxia
De Novo and Bi-allelic Pathogenic Variants in NARS1 Cause Neurodevelopmental Delay Due to Toxic Gain-of-Function and Partial Loss-of-Function Effects.
Autoimmune Diseases
Unique N-terminal extension domain of human asparaginyl-tRNA synthetase elicits CCR3-mediated chemokine activity.
Brain Diseases
The phenotypic variability and natural history of NARS2 associated disease.
Carcinogenesis
Asparaginyl-tRNA Synthetase, a Novel Component of Hippo Signaling, Binds to Salvador and Enhances Yorkie-Mediated Tumorigenesis.
Cataract
Exome Sequencing and Epigenetic Analysis of Twins Who Are Discordant for Congenital Cataract.
Central Nervous System Diseases
The phenotypic variability and natural history of NARS2 associated disease.
Colitis
Nematode asparaginyl-tRNA synthetase resolves intestinal inflammation in mice with T-cell transfer colitis.
Deafness
Mutations of human NARS2, encoding the mitochondrial asparaginyl-tRNA synthetase, cause nonsyndromic deafness and Leigh syndrome.
Diffuse Cerebral Sclerosis of Schilder
Novel variants in the NARS2 gene as a cause of infantile-onset severe epilepsy leading to fatal refractory status epilepticus: case study and literature review.
Diffuse Cerebral Sclerosis of Schilder
PARS2 and NARS2 mutations in infantile-onset neurodegenerative disorder.
Diffuse Cerebral Sclerosis of Schilder
Whole exome sequencing reveals mutations in NARS2 and PARS2, encoding the mitochondrial asparaginyl-tRNA synthetase and prolyl-tRNA synthetase, in patients with Alpers syndrome.
Elephantiasis, Filarial
Brugia malayi Asparaginyl - tRNA Synthetase Stimulates Endothelial Cell Proliferation, Vasodilation and Angiogenesis.
Elephantiasis, Filarial
Expression, localization and alternative function of cytoplasmic asparaginyl-tRNA synthetase in Brugia malayi.
Elephantiasis, Filarial
Immune Response to Brugia malayi Asparaginyl-tRNA Synthetase in Balb/c Mice and Human Clinical Samples of Lymphatic Filariasis.
Elephantiasis, Filarial
Tirandamycins from Streptomyces sp. 17944 Inhibiting the Parasite Brugia malayi Asparagine tRNA Synthetase.
Epilepsy
Lethal NARS2-Related Disorder Associated With Rapidly Progressive Intractable Epilepsy and Global Brain Atrophy.
Epilepsy
Novel variants in the NARS2 gene as a cause of infantile-onset severe epilepsy leading to fatal refractory status epilepticus: case study and literature review.
Epilepsy
PARS2 and NARS2 mutations in infantile-onset neurodegenerative disorder.
Filariasis
Virtual screening of traditional Chinese medicine (TCM) database: identification of fragment-like lead molecules for filariasis target asparaginyl-tRNA synthetase.
Hallux Valgus
Novel phenotype and genotype spectrum of NARS2 and literature review of previous mutations.
Hearing Loss
Mutations of human NARS2, encoding the mitochondrial asparaginyl-tRNA synthetase, cause nonsyndromic deafness and Leigh syndrome.
Hearing Loss
PARS2 and NARS2 mutations in infantile-onset neurodegenerative disorder.
Hearing Loss
The phenotypic variability and natural history of NARS2 associated disease.
Intellectual Disability
PARS2 and NARS2 mutations in infantile-onset neurodegenerative disorder.
Leigh Disease
Mutations of human NARS2, encoding the mitochondrial asparaginyl-tRNA synthetase, cause nonsyndromic deafness and Leigh syndrome.
Leigh Disease
PARS2 and NARS2 mutations in infantile-onset neurodegenerative disorder.
Leigh Disease
The phenotypic variability and natural history of NARS2 associated disease.
Lung Diseases, Interstitial
Anti-KS: identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease.
Microcephaly
De Novo and Bi-allelic Pathogenic Variants in NARS1 Cause Neurodevelopmental Delay Due to Toxic Gain-of-Function and Partial Loss-of-Function Effects.
Mitochondrial Diseases
Novel phenotype and genotype spectrum of NARS2 and literature review of previous mutations.
Mitral Valve Prolapse
Novel phenotype and genotype spectrum of NARS2 and literature review of previous mutations.
Muscular Diseases
PARS2 and NARS2 mutations in infantile-onset neurodegenerative disorder.
Myositis
Do tissue levels of autoantigenic aminoacyl-tRNA synthetase predict clinical disease?
Myositis
Histidyl-tRNA synthetase and asparaginyl-tRNA synthetase, autoantigens in myositis, activate chemokine receptors on T lymphocytes and immature dendritic cells.
Neoplasms
Identification of hub genes and key pathways associated with the progression of gynecological cancer.
Neurodegenerative Diseases
Erratum: PARS2 and NARS2 mutations in infantile-onset neurodegenerative disorder.
Neurodegenerative Diseases
Lethal NARS2-Related Disorder Associated With Rapidly Progressive Intractable Epilepsy and Global Brain Atrophy.
Neurodegenerative Diseases
Novel variants in the NARS2 gene as a cause of infantile-onset severe epilepsy leading to fatal refractory status epilepticus: case study and literature review.
Neurodegenerative Diseases
PARS2 and NARS2 mutations in infantile-onset neurodegenerative disorder.
Osteoarthropathy, Secondary Hypertrophic
Novel phenotype and genotype spectrum of NARS2 and literature review of previous mutations.
Ovarian Neoplasms
Asparagine synthetase: a new potential biomarker in ovarian cancer.
Paraplegia
Novel variants in the NARS2 gene as a cause of infantile-onset severe epilepsy leading to fatal refractory status epilepticus: case study and literature review.
Peripheral Nervous System Diseases
De Novo and Bi-allelic Pathogenic Variants in NARS1 Cause Neurodevelopmental Delay Due to Toxic Gain-of-Function and Partial Loss-of-Function Effects.
Rheumatic Fever
Pathology and etiology of 110 consecutively removed aortic valves.
Seizures
De Novo and Bi-allelic Pathogenic Variants in NARS1 Cause Neurodevelopmental Delay Due to Toxic Gain-of-Function and Partial Loss-of-Function Effects.
Seizures
PARS2 and NARS2 mutations in infantile-onset neurodegenerative disorder.
Status Epilepticus
Novel variants in the NARS2 gene as a cause of infantile-onset severe epilepsy leading to fatal refractory status epilepticus: case study and literature review.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
N381S
mutation decreases NARS2 protein levels in patient fibroblasts and also disrupts dimerization of NARS2
Q274H
the mutation leads to defective oxidative phosphorylation activity involving complex I and IV
V213F
mutation is the underlying cause of nonsyndromic hearing loss, mutation has no effect on oligomerization
Y323*/N381S
mutation results in mitochondrial respiratory chain deficiency and Leigh syndrome, a neurodegenerative disease characterized by symmetric, bilateral lesions in the basal ganglia, thalamus, and brain stem
V213F
the mutation causes nonsyndromic hearing loss
Y323DEL/N381S
the mutations result in mitochondrial respiratory chain deficiency and Leigh syndrome which is a neurodegenerative disease characterized by symmetric, bilateral lesions in the basal ganglia, thalamus, and brain stem
additional information
homozygous missense mutation c.822G>C affects the 3 splice site of exon 7, leading to skipping of the whole exon 7 and a part of exon 8 in the NARS2 mRNA. Upon expression in fibroblasts a specific decrease in the amount of charged mt-tRNAAsn is found. Mutation was found in in two siblings born to consanguineous parents, one presenting with mild intellectual disability and epilepsy in childhood, whereas the other had severe myopathy
additional information
-
the recombinant human enzyme does not induce leukocyte chemotaxis of HEK-293T cells transfected with G-protein-coupled receptors CXCR1 or CXCR2, overview
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Shiba, K.; Motegi, H.; Yoshida, M.; Noda, T.
Human asparaginyl-tRNA synthetase: molecular cloning and the inference of the evolutionary history of Asx-tRNA synthetase family
Nucleic Acids Res.
26
5045-5051
1998
Homo sapiens (O43776), Homo sapiens
brenda
Beaulande, M.; Tarbouriech, N.; Hartlein, M.
Human cytosolic asparaginyl-tRNA synthetase: cDNA sequence, functional expression in Escherichia coli and characterization as human autoantigen
Nucleic Acids Res.
26
521-524
1998
Homo sapiens (O43776), Homo sapiens
brenda
Sukuru, S.C.; Crepin, T.; Milev, Y.; Marsh, L.C.; Hill, J.B.; Anderson, R.J.; Morris, J.C.; Rohatgi, A.; O'Mahony, G.; Groetli, M.; Danel, F.; Page, M.G.; Haertlein, M.; Cusack, S.; Kron, M.A.; Kuhn, L.A.
Discovering new classes of Brugia malayi asparaginyl-tRNA synthetase inhibitors and relating specificity to conformational change
J. Comput. Aided Mol. Des.
20
159-178
2006
Brugia malayi, Homo sapiens
brenda
Ramirez, B.L.; Howard, O.M.; Dong, H.F.; Edamatsu, T.; Gao, P.; Hartlein, M.; Kron, M.
Brugia malayi asparaginyl-transfer RNA synthetase induces chemotaxis of human leukocytes and activates G-protein-coupled receptors CXCR1 and CXCR2
J. Infect. Dis.
193
1164-1171
2006
Brugia malayi, Homo sapiens
brenda
Vanlander, A.V.; Menten, B.; Smet, J.; De Meirleir, L.; Sante, T.; De Paepe, B.; Seneca, S.; Pearce, S.F.; Powell, C.A.; Vergult, S.; Michotte, A.; De Latter, E.; Vantomme, L.; Minczuk, M.; Van Coster, R.
Two siblings with homozygous pathogenic splice-site variant in mitochondrial asparaginyl-tRNA synthetase (NARS2)
Hum. Mutat.
36
222-231
2015
Homo sapiens (Q96I59)
brenda
Simon, M.; Richard, E.M.; Wang, X.; Shahzad, M.; Huang, V.H.; Qaiser, T.A.; Potluri, P.; Mahl, S.E.; Davila, A.; Nazli, S.; Hancock, S.; Yu, M.; Gargus, J.; Chang, R.; Al-Sheqaih, N.; Newman, W.G.; Abdenur, J.; Starr, A.; Hegde, R.; Dorn, T.; Busch, A.; Park, E.; Wu, J.; Schwenzer, H.; Flierl, A.; Florentz, C.
Mutations of human NARS2, encoding the mitochondrial asparaginyl-tRNA synthetase, cause nonsyndromic deafness and Leigh syndrome
PLoS Genet.
11
e1005097
2015
Homo sapiens, Homo sapiens (Q96I59)
brenda